Status:
COMPLETED
Fulvestrant in Postmenopausal Patients With Metastatic Breast Cancer
Lead Sponsor:
Hellenic Oncology Research Group
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
This is a retrospective chart-review study that will be based on the collection of data from electronical or paper-based medical records with available data on patients who have commenced treatment wi...
Detailed Description
To date, there are no available data on the use of fulvestrant in the treatment of postmenopausal women with metastatic breast cancer in current clinical practice in Greece. In view of this significan...
Eligibility Criteria
Inclusion
- Postmenopausal women with ER-positive and/or PgR-positive breast cancer who have failed at least one prior endocrine therapy, either as adjuvant treatment or for the treatment of advanced disease
- Patients who have received treatment with fulvestrant for metastatic breast cancer and have completed/discontinued the treatment regardless of outcome/reason for discontinuation (except for treatment discontinuation for non-clinical reasons)
- Patients who were at postmenopausal status at the time of treatment with fulvestrant
Exclusion
- Patients who are currently undergoing treatment with fulvestrant
- Investigators/treating physicians with no available electronical or paper-based medical records
Key Trial Info
Start Date :
April 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT01399086
Start Date
April 1 2011
End Date
September 1 2011
Last Update
March 13 2012
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
"Ag.Georgios" General Hospital of Chania
Chania, Crete, Greece
2
University Hospital of Crete, Dep of Medical Oncology
Heraklion, Crete, Greece
3
University General Hospital of Alexandroupolis, Dep of Medical Oncology
Alexandroupoli, Greece
4
"Agios Savvas" Anticancer Hospital of Athens
Athens, Greece